NEW YORK (GenomeWeb News) – Beckman Coulter reported after the close of the market on Tuesday that its third-quarter revenues rose 13.4 percent, while its profits slipped on charges.

The firm brought in revenues of $758.8 million for the three months ended Sept. 30, up from $669 million for the third quarter of 2007. Its clinical diagnostics sales increased 13.7 percent to $635.9 million from $559.1 million, and its life sciences sales rose 11.9 percent to $122.9 million from $109.9 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.